Can an ASCUS (Atypical Squamous Cells of Undetermined Significance) finding be reported on a vault smear after a total hysterectomy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can ASCUS Be Reported on Vault Smears After Total Hysterectomy?

Yes, ASCUS findings can technically be reported on vaginal vault smears after total hysterectomy, but routine vault cytology screening is generally not recommended for women who underwent hysterectomy for benign indications without a history of high-grade cervical intraepithelial neoplasia (CIN 2 or higher).

Screening Recommendations After Hysterectomy

The guidelines are clear about when vault cytology should and should not be performed:

Women who should discontinue screening 1, 2, 3:

  • Total hysterectomy performed for benign indications
  • No history of high-grade CIN (CIN 2 or 3)
  • No history of cervical cancer or adenocarcinoma in situ

Women who require continued vault surveillance 2, 3, 2:

  • History of CIN 2 or 3 prior to hysterectomy
  • History of cervical cancer
  • Should continue annual screening until three consecutive satisfactory negative vaginal cytology results are obtained
  • After three consecutive negative results, screening can be discontinued

When ASCUS Can Appear on Vault Smears

While vault cytology is not routinely recommended for most post-hysterectomy patients, when it is performed (either appropriately in high-risk patients or inappropriately in routine screening), ASCUS findings can occur 4:

Clinical significance of vault cytology findings:

  • A 2022 study of 155 women with early cervical cancer treated with hysterectomy found that of 1001 vault smears performed, 1.9% were abnormal 4
  • Low-grade abnormalities (1.6% of smears) all resolved with observation alone 4
  • Importantly, vault cytology did not alter detection of recurrent malignancy - all recurrences had visible lesions or abnormal imaging 4

Key Clinical Pitfalls

Common mistakes to avoid:

  • Do not perform routine vault cytology on women who had hysterectomy for benign reasons without high-grade CIN history - this leads to unnecessary abnormal results that have minimal clinical significance
  • If ASCUS is found on a vault smear in a woman with prior CIN 2/3, manage according to standard ASCCP guidelines with colposcopy or repeat cytology 1
  • Remember that the Bethesda System terminology (including ASCUS) applies to any squamous epithelium, including vaginal vault epithelium 5

Management Algorithm

If ASCUS is reported on a vault smear:

  1. Review surgical history:

    • Was hysterectomy for benign or malignant indication?
    • Was there prior high-grade CIN?
  2. For women with prior CIN 2/3 or cervical cancer:

    • Continue surveillance per guidelines
    • Consider colposcopy of vaginal vault
    • HPV testing may be useful for triage 2
  3. For women with benign hysterectomy indication:

    • Question why vault cytology was performed
    • Low-grade abnormalities typically resolve spontaneously 4
    • Clinical examination is more important than cytology for detecting vault abnormalities

The bottom line: While ASCUS can technically be reported on vault smears using standard Bethesda terminology, the more important question is whether vault cytology should have been performed at all, as guidelines recommend against routine screening in most post-hysterectomy patients 1, 3.

References

Guideline

cervical cancer screening.

Journal of the National Comprehensive Cancer Network : JNCCN, 2014

Guideline

acog releases guidelines on cervical cytology screening.

American family physician, 2003

Guideline

sexually transmitted diseases treatment guidelines, 2010.

MMWR Recommendations and Reports, 2010

Research

Vaginal vault smear cytology in detection of recurrence after hysterectomy for early cervical cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2022

Related Questions

In a patient older than 30 with ASCUS (atypical squamous cells of undetermined significance) on Pap smear and a negative high‑risk HPV (human papillomavirus) test, what is the recommended next step?
What is the appropriate next step in management for a 34‑year‑old woman with persistent low‑grade squamous intraepithelial lesion (LSIL) and high‑risk HPV‑positive Pap smear after a prior benign colposcopy?
For a 58-year-old patient with newly diagnosed atypical squamous cells of undetermined significance (ASC-US), should the next step be a repeat Pap smear in six months or immediate colposcopy?
What is the appropriate management for a 71‑year‑old woman with a prior hysterectomy who now has a low‑grade squamous intraepithelial lesion (LSIL) on a vaginal Pap smear?
What is the appropriate next step in management for a 19-year-old woman with a Pap smear showing ASCUS (Atypical Squamous Cells of Undetermined Significance) and a positive high-risk HPV (Human Papillomavirus) test?
I have a firm subcutaneous cyst larger than 1.5 cm that has grown over the weekend, with no ulceration but some erythema; what is the appropriate evaluation and management?
How are esophageal motility disorders (achalasia, distal esophageal spasm, hypercontractile (jackhammer) esophagus, and ineffective esophageal motility) diagnosed and managed?
How can I manage headache in a patient who has just started an antihypertensive medication?
What oral antibiotic regimen is recommended for an infection resistant to levofloxacin?
What is the appropriate follow‑up for an ASCUS result on vault cytology after a laparoscopic total hysterectomy performed for abnormal uterine bleeding?
Can a patient develop post‑streptococcal glomerulonephritis following a urinary tract infection?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.